Cipolletta, E. ., Nakafero, G. ., McCormick, N. ., Yokose, C. ., Avery, A. J., Mamas, M. A., … Abhishek, A. . (2024). Cardiovascular events in patients with gout initiating urate-lowering therapy with or without colchicine for flare prophylaxis: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data. Lancet Rheumatol. http://doi.org/10.1016/s2665-9913(24)00248-0
A. Avery
First name
A.
Middle name
J.
Last name
Avery
Iyen, B. ., Coupland, C. ., Bell, B. G., Ashcroft, D. M., Orrell, M. W., Bishara, D. ., … Avery, A. J. (2024). Risk of dementia associated with anticholinergic drugs for overactive bladder in adults aged ≥55 years: nested case-control study. BMJ Med, 3, e000799. http://doi.org/10.1136/bmjmed-2023-000799
Mok, P. L. H., Carr, M. J., Guthrie, B. ., Morales, D. R., Sheikh, A. ., Elliott, R. A., … Ashcroft, D. M. (2024). Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study. Bmj, 385, e076268. http://doi.org/10.1136/bmj-2023-076268
Joseph, R. M., Knaggs, R. D., Coupland, C. A. C., Taylor, A. ., Vinogradova, Y. ., Butler, D. ., … Jack, R. H. (2023). Frequency and impact of medication reviews for people aged 65 years or above in UK primary care: an observational study using electronic health records. BMC Geriatr, 23, 435. http://doi.org/10.1186/s12877-023-04143-2
Cipolletta, E. ., Tata, L. J., Nakafero, G. ., Avery, A. J., Mamas, M. A., & Abhishek, A. . (2023). Risk of venous thromboembolism with gout flares. Arthritis Rheumatol. http://doi.org/10.1002/art.42480
Cipolletta, E. ., Tata, L. J., Nakafero, G. ., Avery, A. J., Mamas, M. A., & Abhishek, A. . (2022). Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout. Jama, 328, 440–450. http://doi.org/10.1001/jama.2022.11390
Abhishek, A. ., Tata, L. J., Mamas, M. ., & Avery, A. J. (2022). Has the gout epidemic peaked in the UK? A nationwide cohort study using data from the Clinical Practice Research Datalink, from 1997 to across the COVID-19 pandemic in 2021. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2021-221989
Stocks, S. J., Kontopantelis, E. ., Akbarov, A. ., Rodgers, S. ., Avery, A. J., & Ashcroft, D. M. (2015). Examining variations in prescribing safety in UK general practice: cross sectional study using the Clinical Practice Research Datalink. Bmj. http://doi.org/10.1136/bmj.h5501
Stocks, S. J., Kontopantelis, E. ., Webb, R. T., Avery, A. J., Burns, A. ., & Ashcroft, D. M. (2017). Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General Practice. Drug Saf. http://doi.org/10.1007/s40264-017-0538-x